Citigroup Maintains Buy on Biomea Fusion, Lowers Price Target to $53
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Yigal Nochomovitz maintains a Buy rating on Biomea Fusion (NASDAQ:BMEA) but lowers the price target from $55 to $53.
May 18, 2023 | 10:22 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Citigroup maintains a Buy rating on Biomea Fusion (NASDAQ:BMEA) and lowers the price target from $55 to $53.
The news of Citigroup maintaining a Buy rating on Biomea Fusion is positive for the stock. However, the lowering of the price target from $55 to $53 may create some uncertainty among investors. The overall impact on the stock price is expected to be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100